CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Developments in the field of regenerative medicine
4.1.2. Increasing incidence of sports injuries and road traffic accidents
4.1.3. Rapid Growth in Geriatric Population
4.1.4. Advancements in regenerative medicines
4.2. Market Restraints & Challenges
4.2.1. High costs and extensive clinical data requirements for launching new bone cement
4.2.2. Development of novel biomaterials with high mechanical properties and adhesion
strength
4.2.3. Unfavourable reimbursement scenario
CHAPTER 5. GLOBAL BONE CEMENT & GLUE MARKET – BY TYPE
5.1. Bone Glue
5.1.1. Synthetic Bone Glue
5.1.2. Natural Bone Glue
5.2. Bone Cement
5.2.1. Glass Polyalkenoate Cement
5.2.2. Calcium Phosphate Cement
5.2.3. PMMA Cement
5.2.4. Antibiotic-Loaded Bone Cement
5.2.5. Non-Antibiotic-Loaded Bone Cement
CHAPTER 6. GLOBAL BONE CEMENT & GLUE MARKET – BY APPLICATION
6.1. Kyphoplasty
6.2. Vertebroplasty
6.3. Arthroplasty
6.3.1. Total Shoulder Arthroplasty
6.3.2. Total Hip Arthroplasty
6.3.3. Total Knee Arthroplasty
6.4. Others
CHAPTER 7. GLOBAL BONE CEMENT & GLUE MARKET – BY END USER
7.1. Ambulatory Surgery Centers
7.2. Hospitals & Clinics
7.3. Others
CHAPTER 8. GLOBAL BONE CEMENT & GLUE MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL BONE CEMENT & GLUE MARKET - COMPANY PROFILES
9.1. Cardinal Health, Inc.
9.2. Exactech, Inc.
9.3. Teknimed SA
9.4. Heraeus Medical GmbH
9.5. Cryolife, Inc.
9.6. DJO Incorporated
9.7. Triumph Group
9.8. Arthrex, Inc.
9.9. Zimmer Biomet Holdings, Inc.
9.10. Johnson & Johnson Incorporated.
9.11. Smith & Nephew PLC
9.12. Stryker Corporation
CHAPTER 10. GLOBAL BONE CEMENT & GLUE MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
